Phase I Study to Evaluate Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Fosfomycin tromethamine (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms PROOF
- 08 Oct 2017 Results evaluating safety and tolerability of two dosing regimens of Fosfomycin-tromethamine in healthy adult subjects presented at the IDWeek 2017
- 08 Oct 2017 Results presented at the IDWeek 2017
- 28 Nov 2016 Status changed from active, no longer recruiting to completed.